Top Urology Specialist Professor Ma Lulin’s Regular In-Hospital Visits Enhance Precision Care

[Daily National Chief Expert Consultations] Top Urology Specialist Professor Ma Lulin’s Regular In-Hospital Visits Enhance Precision Care in Our Urology Department

On February 1, Professor Ma Lulin, a leading figure in the field of urology in China and former head of the Department of Urology at Peking University Third Hospital, officially began his regular in-hospital presence at the Lanzhou Heavy Ion Center of Gansu Wuwei Cancer Hospital. Operating under a model of "full-cycle consultation and precision diagnosis and treatment," Professor Ma will provide weekly scheduled consultations at the center. His expertise will inject core momentum into the high-quality development of the center’s radiation oncology discipline and drive a leap forward in clinical service standards. This initiative also serves as a vivid example of our hospital's new paradigm for high-quality medical services: "localizing high-end medical resources and making chief expert services part of daily practice."

Professor Ma Lulin, a distinguished second-level professor, doctoral supervisor, and postdoctoral co-supervisor at Peking University, has dedicated nearly four decades to the field of urology. Currently serving as the Vice President of the Haidian Branch of Peking University Third Hospital, he is a leading authority in China in kidney transplantation and the diagnosis and treatment of complex urological tumors. His expertise in living donor kidney transplantation and simultaneous pancreas-kidney transplantation has reached internationally advanced levels. He has also achieved profound mastery in challenging surgical procedures such as robot-assisted/laparoscopic resection of large adrenal tumors, radical surgery for renal cell carcinoma with inferior vena cava tumor thrombus, nerve-sparing radical prostatectomy, and Studer orthotopic neobladder reconstruction. Over the years, he has alleviated the suffering of over ten thousand patients, earning an exceptional reputation within the industry.

During his ward rounds, Professor Ma Lulin meticulously examined each patient's condition. For complex cases, he leveraged his extensive clinical experience and the latest advancements in diagnosis and treatment both domestically and internationally. Through hands-on guidance and face-to-face instruction, he provided a series of professional and scientific recommendations covering optimized treatment plans, precise complication management, and personalized rehabilitation guidance. His expertise has charted a clear direction for patients' subsequent treatment, enabling them to access top-tier urological care from a leading national expert right at their doorstep.

In recent years, Gansu Wuwei Cancer Hospital has achieved significant milestones in advancing the Heavy Ion Therapy Alliance and establishing 50 expert workstations. As the only hospital in the world operating two heavy ion therapy systems simultaneously, Gansu Wuwei Cancer Hospital remains steadfastly committed to the continuous development and innovation of cancer treatment technologies. The Lanzhou Heavy Ion Center is the second domestically developed heavy ion clinical application center independently operated by Gansu Wuwei Cancer Hospital. This system commenced clinical operations at the Lanzhou Heavy Ion Center on November 15, 2024. To date, the center has completed photon and heavy ion treatments for over 400 patients, covering conditions such as lung cancer, pancreatic cancer, liver cancer, and glioblastoma.

Professor Ma Lulin’s regular in-hospital consultations and professional guidance represent another manifestation of the Lanzhou Heavy Ion Center’s commitment to the philosophy of “gathering cutting-edge global technologies to benefit cancer patients worldwide.” The center not only actively adopts an open and inclusive approach to introduce internationally leading heavy ion therapy technologies, building bridges for cross-border academic exchanges and engaging in deep technical dialogues and experience sharing with top experts from countries such as Japan and Germany, but also demonstrates a pragmatic and dedicated spirit by actively integrating authoritative domestic clinical expertise. Through regular ward rounds and personalized consultation services, it promotes the standardization of clinical practices and the homogenization of diagnostic and treatment standards. By continuously deepening its disciplinary development, the center brings the light of hope to cancer patients.

Looking ahead, the Lanzhou Heavy Ion Center of Gansu Wuwei Cancer Hospital will continue to build high-level platforms for academic exchange and expert collaboration, consistently attracting top-tier medical resources from both domestic and international sources. With a focus on disciplinary development as its core and technological innovation as its driving force, the center will persistently enhance its core diagnostic and treatment capabilities and service quality. By integrating advanced heavy ion therapy technologies with top-tier specialized clinical services, it aims to benefit more cancer patients and inject stronger medical momentum into the development of healthcare in Northwest China.